Analyst ratings for Marvell Technology

On February 26, 2024, UBS raised the price target from $70 to $83, maintaining a Buy rating. On January 23, 2024, Cantor Fitzgerald initiated coverage with an Overweight rating and a price target of $80, showing a 16.94% upside. Raymond James maintained an Outperform rating on January 19, 2024, increasing the price target from $62 to $78, with a 14.02% upside. Barclays and Citigroup both maintained their ratings on January 16 and 12, 2024, respectively, with price target changes from $70 to $75 and $61 to $75, both with a Buy or Overweight rating. In December 2023, Barclays, UBS, and Piper Sandler all maintained their Overweight or Buy ratings with price target adjustments.

Date	Upside/Downside	Analyst Firm	Price Target Change	Rating Change	Previous / Current Rating
02/26/2024	21.33%	UBS	$70 → $83	Maintains	Buy
01/23/2024	16.94%	Cantor Fitzgerald	→ $80	Initiates Coverage On	→ Overweight
01/19/2024	14.02%	Raymond James	$62 → $78	Maintains	Outperform
01/16/2024	9.63%	Barclays	$70 → $75	Maintains	Overweight
01/12/2024	9.63%	Citigroup	$61 → $75	Maintains	Buy
12/05/2023	2.32%	Barclays	$75 → $70	Maintains	Overweight
12/01/2023	2.32%	UBS	$75 → $70	Maintains	Buy
12/01/2023	2.32%	Piper Sandler	$75 → $70	Maintains	Overweight
12/01/2023	9.63%	Benchmark	→ $75	Reiterates	Buy → Buy
12/01/2023	-4.98%	Susquehanna	$70 → $65	Maintains	Positive
12/01/2023	-7.91%	Morgan Stanley	$65 → $63	Maintains	Equal-Weight
12/01/2023	-9.37%	Raymond James	$64 → $62	Maintains	Outperform

On 12/01/2023, Needham adjusted the target price to $65, with a decrease of 4.98%, maintaining a Buy rating.
Rosenblatt reiterated the Buy rating on 12/01/2023, setting the target price at $100, with an increase of 46.18%.
Keybanc maintained an Overweight rating on 12/01/2023, lowering the target price from $80 to $70, with a 2.32% increase.
Rosenblatt reiterated the Buy rating on 11/30/2023, with a target price of $100 and a 46.18% increase.
Roth MKM initiated coverage on 11/14/2023, setting the target price at $60, with a -12.29% change to a Buy rating.
On 08/25/2023, B of A Securities maintained a Buy rating, adjusting the target price from $80 to $75, with a 9.63% increase.
Morgan Stanley maintained an Equal-Weight rating on 08/25/2023, adjusting the target price from $68 to $65, with a -4.98% change.
B. Riley Securities maintained a Buy rating on 08/25/2023, adjusting the target price from $75 to $77, with a 12.56% increase.
Oppenheimer reiterated an Outperform rating on 08/25/2023, setting the target price at $70, with a 2.32% increase.
Needham reiterated a Buy rating on 08/25/2023, setting the target price at $65, with a -4.98% change.
Rosenblatt reiterated the Buy rating on 08/25/2023, setting the target price at $100, with a 46.18% increase.
Susquehanna maintained a Positive rating on 08/23/2023, adjusting the target price from $60 to $70, with a 2.32% increase.
Rosenblatt reiterated the Buy rating on 08/22/2023, setting the target price at $100, with a 46.18% increase.
B. Riley Securities upgraded the rating from Neutral to Buy on 08/18/2023, adjusting the target price from $60 to $75, with a 9.63% increase.
07/20/2023: Stifel maintains a Buy rating with a target price raised from $65 to $75, representing a 9.63% increase. Barclays also maintains an Overweight rating with the target price adjusted from $55 to $75. Wolfe Research initiates coverage with an Outperform rating and a target price of $80, reflecting a 16.94% increase.
07/11/2023: Keybanc maintains an Overweight rating with the target price raised from $70 to $80, a 16.94% increase.
06/21/2023: Stifel reiterates a Buy rating with a target price of $65, a -4.98% change.
06/16/2023: Morgan Stanley maintains an Equal-Weight rating with the target price adjusted from $55 to $68, a -0.6% change.
05/30/2023: Goldman Sachs maintains a Buy rating with the target price raised from $46 to $60, a -12.29% change.
05/26/2023: JP Morgan maintains an Overweight rating with the target price raised from $60 to $70, a 2.32% increase. Craig-Hallum maintains a Buy rating with the target price adjusted from $56 to $67, a -2.06% change. Oppenheimer reiterates an Outperform rating with a target price of $70. Evercore ISI Group maintains an Outperform rating with the target price adjusted from $60 to $70, a 2.32% increase. Raymond James maintains an Outperform rating with the target price adjusted from $50 to $64, a -6.45% change. Morgan Stanley maintains an Equal-Weight rating with the target price adjusted from $45 to $55, a -19.6% change. Susquehanna maintains a Positive view with the target price raised from $53 to $60, a -12.29% change.
On May 26, 2023, Wells Fargo maintained an 'Overweight' rating for Wells Fargo, with a price target adjusted from $54 to $65, showing a decrease of 4.98%.
TD Cowen also maintained an 'Outperform' rating for TD Cowen on the same day, with a price target adjusted from $50 to $65, reflecting a decrease of 4.98%.
Stifel kept a 'Buy' rating for Stifel on May 26, 2023, with the price target adjusted from $56 to $65, a decrease of 4.98%.
B of A Securities maintained a 'Buy' rating for B of A Securities on May 26, 2023, with the price target adjusted from $51 to $70, an increase of 2.32%.
Rosenblatt reiterated a 'Buy' rating for Rosenblatt on May 26, 2023, with the price target remaining at $100, an increase of 46.18%.
Needham also reiterated a 'Buy' rating for Needham on May 26, 2023, with the price target adjusted from $50 to $65, a decrease of 4.98%.
Barclays maintained an 'Overweight' rating for Barclays on May 26, 2023, with the price target adjusted from $45 to $55, a decrease of 19.6%.
Citigroup maintained a 'Buy' rating for Citigroup on May 26, 2023, with the price target adjusted from $58 to $61, a decrease of 10.83%.
Deutsche Bank maintained a 'Buy' rating for Deutsche Bank on May 26, 2023, with the price target adjusted from $50 to $65, a decrease of 4.98%.
Keybanc maintained an 'Overweight' rating for Keybanc on May 26, 2023, with the price target adjusted from $60 to $70, an increase of 2.32%.
On May 19, 2023, Oppenheimer reiterated an 'Outperform' rating for Oppenheimer, with the price target remaining at $70, showing an increase of 2.32%.
Stifel maintained a 'Buy' rating for Stifel on April 19, 2023, with the price target adjusted from $58 to $56, a decrease of 18.14%.
On March 23, 2023, B of A Securities reiterated a 'Neutral' rating for B of A Securities, with the price target remaining unspecified, showing a decrease of 25.45%.
Susquehanna reiterated a 'Positive' rating for Susquehanna on March 9, 2023, with the price target remaining at $50, showing a decrease of 26.91%.
03/06/2023: Goldman Sachs downgraded from $54 to $46, maintaining a Buy rating with a decrease of 32.76%.
03/03/2023:
- Craig-Hallum downgraded from $63 to $56, maintaining a Buy rating with a decrease of 18.14%.
- Morgan Stanley adjusted from $41 to $45, maintaining an Equal-Weight rating with a decrease of 34.22%.
- TD Cowen revised from $55 to $50, maintaining an Outperform rating with a decrease of 26.91%.
- B of A Securities downgraded from $52 to $51, maintaining a Buy rating with a decrease of 25.45%.
- Citigroup adjusted from $65 to $58, maintaining a Buy rating with a decrease of 15.22%.
- Goldman Sachs revised from $54 to $46, maintaining a Buy rating with a decrease of 32.76%.
- Piper Sandler adjusted from $55 to $50, maintaining an Overweight rating with a decrease of 26.91%.
- JP Morgan revised from $72 to $60, maintaining an Overweight rating with a decrease of 12.29%.
- Credit Suisse adjusted from $56 to $53, maintaining an Outperform rating with a decrease of 22.53%.
- Deutsche Bank revised from $55 to $50, maintaining a Buy rating with a decrease of 26.91%.
- Susquehanna revised from $55 to $50, maintaining a Positive rating with a decrease of 26.91%.
- Raymond James adjusted from $54 to $50, maintaining an Outperform rating with a decrease of 26.91%.
- Needham maintained a Buy rating with no price change.
03/03/2023: Rosenblatt maintains a Buy rating, with a target price lowered from $125 to $100, a decrease of 46.18%. Keybanc also maintains an Overweight rating, with the target price adjusted from $65 to $60, a decrease of 12.29%.
03/02/2023: Raymond James reinstates coverage with an Outperform rating and a target price of $54, a decrease of 21.06%.
03/01/2023: Rosenblatt reiterates a Buy rating with a target price of $125, an increase of 82.72%.
02/22/2023: Susquehanna maintains a Positive rating, with the target price lowered from $60 to $55, a decrease of 19.6%.
01/23/2023: Barclays maintains an Overweight rating, with the target price adjusted from $55 to $45, a decrease of 34.22%.
12/15/2022: Evercore ISI Group maintains an Outperform rating, with the target price unchanged at $60, a decrease of 12.29%.
12/02/2022: Various analysts maintain their ratings with target price adjustments:
- Craig-Hallum: Buy rating, target price lowered from $90 to $63, a decrease of 7.91%.
- TD Cowen: Outperform rating, target price lowered from $70 to $55, a decrease of 19.6%.
- Citigroup: Buy rating, target price lowered from $71 to $65, a decrease of 4.98%.
- Morgan Stanley: Equal-Weight rating, target price lowered from $60 to $41, a decrease of 40.07%.
- UBS: Buy rating, target price lowered from $80 to $75, an increase of 9.63%.
- JP Morgan: Overweight rating, target price lowered from $75 to $72, an increase of 5.25%.
- Goldman Sachs: Buy rating, target price lowered from $62 to $54, a decrease of 21.06%.
On 12/02/2022, Wells Fargo downgraded the stock by 21.06% from $58 to $54, maintaining an Overweight rating.
Barclays also downgraded the stock on 12/02/2022 by 19.6% from $60 to $55, with an Overweight rating.
Raymond James maintained an Outperform rating on 12/02/2022, lowering the stock by 12.29% from $80 to $60.
Piper Sandler maintained an Overweight rating on 12/02/2022, decreasing the stock by 19.6% from $80 to $55.
Needham maintained a Buy rating on 12/02/2022, reducing the stock by 26.91% from $64 to $50.
Keybanc maintained an Overweight rating on 12/02/2022, lowering the stock by 4.98% from $75 to $65.
On 11/28/2022, Oppenheimer maintained an Outperform rating, with a 16.94% increase from $90 to $80.
Credit Suisse initiated coverage on 11/16/2022 with an Outperform rating, without specifying the price.
Deutsche Bank maintained a Buy rating on 10/18/2022, decreasing the stock by 19.6% from $65 to $55.
Citigroup maintained a Buy rating on 10/11/2022, with a slight decrease from $74 to $71.
Wells Fargo upgraded the stock on 10/11/2022 from Equal-Weight to Overweight, with a 15.22% decrease from an unspecified price to $58.
B. Riley Securities maintained a Neutral rating on 10/04/2022, lowering the stock by 23.99% from $63 to $52.
Stifel maintained a Buy rating on 09/29/2022, with a 2.32% increase from $78 to $70.
Exane BNP Paribas initiated coverage on 09/13/2022 with an Outperform rating, without specifying the price.
On 08/29/2022, Citigroup maintained a Buy rating with a target price change from $78 to $74, representing a decrease of 8.17%.
On 08/26/2022, Morgan Stanley maintained an Equal-Weight rating with a target price change from $62 to $60, a decrease of 12.29%.
On 08/26/2022, Goldman Sachs maintained a Buy rating with a target price change from $55 to $62, a decrease of 9.37%.
On 08/26/2022, Wells Fargo maintained an Equal-Weight rating with a target price change from $65 to $58, a decrease of 15.22%.
On 08/26/2022, Keybanc maintained an Overweight rating with a target price change from $90 to $75, an increase of 9.63%.
On 07/25/2022, Barclays maintained an Overweight rating with a target price change from $80 to $60, a decrease of 12.29%.
On 07/22/2022, Benchmark assumed coverage with a Buy rating and a target price of $70, representing an increase of 2.32%.
On 07/20/2022, Deutsche Bank maintained a Buy rating with a target price change from $75 to $65, a decrease of 4.98%.
On 07/18/2022, Evercore ISI Group maintained an Outperform rating with a target price change from $85 to $70, a decrease of 2.32%.
On 06/29/2022, B of A Securities maintained a Buy rating with a target price change from $90 to $60, a decrease of 12.29%.
On 06/15/2022, B. Riley Securities downgraded from Buy to Neutral with a target price change from $75 to $63, a decrease of 7.91%.
On 06/10/2022, Morgan Stanley maintained an Equal-Weight rating with a target price change from $68 to $62, a decrease of 9.37%.
On 05/27/2022, Citigroup maintained a Buy rating with a target price change from $90 to $78, a decrease of 14.02%.
On 05/27/2022, BMO Capital maintained an Outperform rating with a target price change from $98 to $82, a decrease of 19.87%.
On May 27, 2022, Cowen & Co. maintained an Outperform rating, with a target price adjusted from $100 to $85, representing a change of -24.25%.
B of A Securities also maintained a Buy rating on the same day, with the target price adjusted from $100 to $90, a change of -31.56%.
Morgan Stanley maintained an Equal-Weight rating on May 27, 2022, with the target price adjusted from $80 to $68, a change of -0.6%.
Needham kept a Buy rating on May 27, 2022, with the target price maintained at $105, but adjusted to $75, a change of -9.63%.
Keybanc maintained an Overweight rating on May 27, 2022, with the target price adjusted from $95 to $90, a change of -31.56%.
On May 25, 2022, Susquehanna maintained a Positive rating, with the target price adjusted from $105 to $90, a change of -31.56%.
B. Riley Securities maintained a Buy rating on May 23, 2022, with the target price adjusted from $95 to $72, a change of -5.25%.
UBS also maintained a Buy rating on May 23, 2022, with the target price adjusted from $95 to $80, a change of -16.94%.
Oppenheimer maintained an Outperform rating on May 20, 2022, with the target price adjusted from $110 to $90, a change of -31.56%.
Barclays maintained an Overweight rating on April 25, 2022, with the target price adjusted from $90 to $80, a change of -16.94%.
Raymond James upgraded from Market Perform to Outperform on April 25, 2022, with the target price not specified.
Deutsche Bank maintained a Buy rating on April 20, 2022, with the target price adjusted from $90 to $80, a change of -16.94%.
On March 7, 2022, Susquehanna maintained a Positive rating, with the target price adjusted from $100 to $105, a change of 53.49%.
Summit Insights Group downgraded from Buy to Hold on March 4, 2022, with details not provided.
On March 4, 2022, Morgan Stanley maintained an Equal-Weight rating with a target price adjustment from $86 to $80, representing a change of -16.94%.
B. Riley Securities also maintained a Buy rating on the same day, with a target price adjustment from $115 to $95, a change of -38.87%.
Deutsche Bank maintained a Buy rating with a target price adjustment from $100 to $90 on March 4, 2022, reflecting a change of -31.56%.
Wells Fargo, on March 4, 2022, maintained an Equal-Weight rating with a target price adjustment from $80 to $70, a change of -2.32%.
Rosenblatt kept a Buy rating on March 4, 2022, with a target price adjustment from $120 to $125, a change of 82.72%.
Needham also maintained a Buy rating on March 4, 2022, with a target price adjustment from $115 to $105, a change of 53.49%.
On January 4, 2022, Needham maintained a Buy rating with a target price adjustment from $100 to $115, a change of 68.1%.
Citigroup, on December 21, 2021, maintained a Buy rating with a target price adjustment from $87 to $97, a change of 41.79%.
B of A Securities, on December 3, 2021, maintained a Buy rating with a target price adjustment from $80 to $115, a change of 68.1%.
Citigroup, on December 3, 2021, maintained a Buy rating with a target price adjustment from $70 to $87, a change of 27.17%.
Deutsche Bank, on December 3, 2021, maintained a Buy rating with a target price adjustment from $76 to $100, a change of 46.18%.
Oppenheimer, on December 3, 2021, maintained an Outperform rating with a target price adjustment from $100 to $110, a change of 60.8%.
Rosenblatt, on December 3, 2021, maintained a Buy rating with a target price adjustment from $100 to $120, a change of 75.41%.
Cowen & Co., on December 3, 2021, upgraded their rating from Market Perform to Outperform with a target price adjustment from $66 to $100, a change of 46.18%.
On December 3, 2021, Needham maintains a Buy rating with a target price raised from $75 to $100, representing a 46.18% increase.
Morgan Stanley also maintains their Equal-Weight rating on the same day, with the target price adjusted from $63 to $86, a 25.71% increase.
Stifel maintains a Buy rating on December 3, 2021, with the target price raised from $80 to $100, a 46.18% increase.
B. Riley Securities maintains a Buy rating with the target price increased from $90 to $115 on December 3, 2021, reflecting a 68.1% rise.
Goldman Sachs upgrades from Neutral to Buy on December 3, 2021, with the target price adjusted from $63 to $95, a 38.87% increase.
Wells Fargo maintains an Equal-Weight rating on December 3, 2021, with the target price raised from $62 to $80, a 16.94% increase.
BMO Capital maintains an Outperform rating on December 3, 2021, with the target price adjusted from $85 to $98, a 43.25% increase.
Credit Suisse maintains an Outperform rating on December 3, 2021, with the target price raised from $85 to $105, a 53.49% increase.
UBS maintains a Buy rating on December 3, 2021, with the target price adjusted from $87 to $95, a 38.87% increase.
Keybanc maintains an Overweight rating on December 3, 2021, with the target price raised from $80 to $95, a 38.87% increase.
Susquehanna maintains a Positive rating on December 1, 2021, with the target price adjusted from $75 to $82, a 19.87% increase.
B. Riley Securities maintains a Buy rating on November 29, 2021, with the target price increased from $83 to $90, a 31.56% rise.
Oppenheimer maintains an Outperform rating on November 23, 2021, with the target price raised from $75 to $100, a 46.18% increase.
On October 7, 2021, TD Cowen maintains a Market Perform rating with the target price adjusted from $57 to $66, a decrease of 3.52%.
10/07/2021
- B of A Securities: 16.94% increase, target price $75 → $80, maintains Buy rating.
- Morgan Stanley: 7.91% decrease, target price $61 → $63, maintains Equal-Weight rating.
- B. Riley Securities: 21.33% increase, target price $75 → $83, maintains Buy rating.
- Jefferies: 19.87% increase, target price $78 → $82, maintains Buy rating.
- Craig-Hallum: 24.25% increase, target price $63 → $85, upgrades from Hold to Buy.
- Needham: 9.63% increase, target price $69 → $75, maintains Buy rating.
- Rosenblatt: 46.18% increase, target price $85 → $100, maintains Buy rating.
- Credit Suisse: 24.25% increase, target price $70 → $85, maintains Outperform rating.
- Keybanc: 16.94% increase, target price $70 → $80, maintains Overweight rating.
09/28/2021
- TD Cowen: 16.68% decrease, target price unchanged at $57, reiterates Market Perform rating.
08/27/2021
- TD Cowen: 16.68% decrease, target price $55 → $57, maintains Market Perform rating.
- B of A Securities: 9.63% increase, target price $74 → $75, maintains Buy rating.
- Citigroup: 2.32% increase, target price $64 → $70, maintains Buy rating.
- Craig-Hallum: 7.91% decrease, target price unchanged at $63, downgrades from Buy to Hold.
On 08/27/2021, Morgan Stanley maintained an Equal-Weight rating with a price target of $61, representing a -10.83% change.
Wells Fargo also maintained an Equal-Weight rating on the same day, adjusting the price target from $50 to $62, a -9.37% change.
Needham kept a Buy rating with a price target of $69, up from $67.5, reflecting a 0.86% change on 08/27/2021.
Oppenheimer maintained an Outperform rating with a price target of $75, previously $70, showing a 9.63% change on 08/27/2021.
Barclays and Keybanc both maintained an Overweight rating on 08/27/2021, with price targets adjusted from $60 to $70 and $65 to $70, respectively, both showing a 2.32% change.
On 08/23/2021, TD Cowen maintained a Market Perform rating with a price target of $55, previously $50, reflecting a -19.6% change.
Morgan Stanley also maintained an Equal-Weight rating on 08/23/2021, adjusting the price target from $49 to $57, a -16.68% change.
Credit Suisse maintained an Outperform rating on 08/04/2021, with a price target of $70, previously $60, showing a 2.32% change.
Needham kept a Buy rating on 08/04/2021, adjusting the price target from $55 to $67.5, a -1.33% change.
B of A Securities maintained a Buy rating on 07/15/2021, with a price target of $74, previously $62, showing an 8.17% change.
Keybanc maintained an Overweight rating on 07/06/2021, with a price target adjusted from $60 to $65, reflecting a -4.98% change.
On 06/08/2021, B of A Securities maintained a Buy rating with a price target of $62, previously $60, showing a -9.37% change.
Keybanc also maintained an Overweight rating on 06/08/2021, adjusting the price target from $55 to $60, a -12.29% change.
06/08/2021: Needham predicts a -19.6% change, setting the target price from $50 to $55, maintaining a Buy rating. Rosenblatt forecasts a 2.32% change, adjusting the target price from $60 to $70, also maintaining a Buy rating.
05/13/2021: Needham anticipates a -26.91% change, adjusting the target price from $47 to $50, maintaining a Buy rating.
04/26/2021: B of A Securities expects a -12.29% change, setting the target price from $58 to $60, maintaining a Buy rating.
03/08/2021: BMO Capital predicts a -26.91% change, adjusting the target price from $45 to $50, upgrading from Market Perform to Outperform.
03/01/2021: Morgan Stanley forecasts a -28.37% change, setting the target price from $44 to $49, maintaining an Equal-Weight rating.
01/25/2021: Citigroup anticipates a -6.45% change, adjusting the target price from $50 to $64, maintaining a Buy rating.
12/14/2020: Morgan Stanley expects a -35.68% change, setting the target price from $42 to $44, maintaining an Equal-Weight rating.
12/04/2020: Morgan Stanley predicts a -38.61% change, adjusting the target price from $40 to $42, maintaining an Equal-Weight rating.
10/30/2020: Craig-Hallum forecasts a -29.83% change, setting the target price from $44 to $48, upgrading from Hold to Buy. Morgan Stanley anticipates a -41.53% change, maintaining an Equal-Weight rating.
10/20/2020: Keybanc predicts a -19.6% change, reinstating the target price to $55 with an Overweight rating.
10/09/2020: Citigroup anticipates a -26.91% change, adjusting the target price from $43 to $50, maintaining a Buy rating. Craig-Hallum downgrades from Buy to Hold.
10/09/2020: Benchmark downgraded by -26.91% from $40 to $50, rating maintained as Buy.
10/09/2020: Needham downgraded by -31.3% from $39 to $47, rating maintained as Buy.
10/06/2020: UBS downgraded by -31.3% from $38 to $47, rating maintained as Buy.
10/05/2020: B. Riley Securities reiterated with a -29.83% change from $42 to $48, rating remains Buy.
10/02/2020: Rosenblatt reiterated with a -12.29% change from $50 to $60, rating remains Buy.
09/02/2020: Argus Research downgraded by -26.91% from $40 to $50, rating maintained as Buy.
08/28/2020: Rosenblatt downgraded by -26.91% from $42 to $50, rating maintained as Buy.
08/28/2020: Morgan Stanley downgraded by -45.91% from $36 to $37, rating maintained as Equal-Weight.
08/28/2020: Cowen & Co. upgraded from Underperform to Market Perform, with a -54.68% change to $31.
08/27/2020: Credit Suisse reinstated with an upgrade to Outperform, with a -34.22% change to $45.
08/03/2020: B of A Securities downgraded by -26.91% from $45 to $50, rating maintained as Buy.
07/20/2020: Barclays downgraded by -41.53% from $35 to $40, rating maintained as Overweight.
07/15/2020: Wells Fargo downgraded from Overweight to Equal-Weight, with a -48.84% change to $35.
06/29/2020: UBS downgraded by -44.45% from $35 to $38, rating maintained as Buy.
06/16/2020: Morgan Stanley maintained an Equal-Weight rating, with a decrease of 47.38% from $33.5 to $36.
06/01/2020: Morgan Stanley maintained an Equal-Weight rating, with a decrease of 51.03% from $25 to $33.5.
05/29/2020: CFRA maintained a Buy rating, with a decrease of 48.84% from $27 to $35.
05/29/2020: B. Riley Securities maintained a Buy rating, with a decrease of 44.45% from $34 to $38.
05/29/2020: Morgan Stanley maintained an Equal-Weight rating, with a decrease of 51.03% from $25 to $33.5.
05/29/2020: Rosenblatt reiterated a Buy rating, with a decrease of 38.61% from $32 to $42.
05/29/2020: Needham maintained a Buy rating, with a decrease of 50.3% from $28 to $34.
05/27/2020: Benchmark maintained a Buy rating, with a decrease of 48.84% from $30 to $35.
05/22/2020: B. Riley Securities maintained a Buy rating, with a decrease of 50.3% from $31 to $34.
05/21/2020: Citigroup maintained a Buy rating, with a decrease of 48.84% from $31 to $35.
04/15/2020: Needham maintained a Buy rating, with a decrease of 59.07% from $29 to $28.
04/13/2020: B. Riley Securities maintained a Buy rating, with a decrease of 54.68% from $25 to $31.
03/19/2020: B. Riley Securities maintained a Buy rating, with a decrease of 63.46% from $32 to $25.
03/06/2020: Citigroup maintained a Buy rating, with a decrease of 54.68% from $30 to $31.
On 03/05/2020, Stifel maintains a Buy rating with a target price of $32, despite a -53.22% change.
Piper Sandler reiterates an Overweight rating with a target price adjustment from $30 to $32 on 03/05/2020.
Morgan Stanley maintains an Equal-Weight rating with a target price adjustment from $24 to $25 on 03/05/2020, reflecting a -63.46% change.
B. Riley Securities maintains a Buy rating with a target price adjustment from $28 to $32 on 03/05/2020, despite a -53.22% change.
On 03/02/2020, B. Riley Securities maintains a Buy rating with a target price adjustment from $32 to $28, reflecting a -59.07% change.
SMBC Nikko initiates coverage on 02/11/2020 with an Outperform rating, setting the target price at $30, resulting in a -56.15% change.
Cowen & Co. downgrades from Outperform to Underperform on 02/07/2020, with a target price adjustment from $27 to $18, reflecting a -73.69% change.
Citigroup maintains a Buy rating with a target price adjustment from $29 to $30 on 12/05/2019, resulting in a -56.15% change.
JP Morgan maintains an Overweight rating with a target price adjustment from $27 to $31 on 12/04/2019, reflecting a -54.68% change.
Morgan Stanley maintains an Equal-Weight rating with a target price adjustment from $20 to $24 on 12/04/2019, resulting in a -64.92% change.
BMO Capital downgrades from Outperform to Market Perform on 12/04/2019.
Wells Fargo upgrades from Market Perform to Outperform on 11/04/2019, with a target price adjustment from $25 to $32, reflecting a -53.22% change.
Stifel reinstates a Buy rating with a target price set at $29 on 10/04/2019, resulting in a -57.61% change.
08/30/2019: Craig-Hallum upgraded from Hold to Buy.
08/21/2019: Benchmark's target price decreased by 56.15% to $30, and it assumes a Buy rating.
07/22/2019: Goldman Sachs downgraded from $24 to $25, changing from Buy to Neutral.
07/17/2019: Citigroup maintained a Buy rating with a target price adjustment from $27 to $30.
07/15/2019: William Blair initiated coverage with an Outperform rating.
06/19/2019: Raymond James initiated coverage with a Market Perform rating.
05/31/2019: B. Riley Securities maintained a Buy rating with a target price adjustment from $30 to $28.
05/31/2019: Morgan Stanley maintained an Equal-Weight rating with a target price adjustment from $19 to $20.
05/31/2019: Citigroup maintained a Buy rating with a target price adjustment from $28 to $27.
05/31/2019: MKM Partners maintained a Buy rating with a target price adjustment from $25 to $28.
05/15/2019: Wells Fargo initiated coverage with a Market Perform rating and a target price of $24.
04/24/2019: UBS maintained a Buy rating with a target price adjustment from $22 to $29.
04/17/2019: B of A Securities reiterated a Buy rating with a target price adjustment from $24 to $28.

04/17/2019: Citigroup maintained a Buy rating with a target price adjustment from $22 to $28.

Date	Up/Down	Analysis Firm	Target Price Change	Rating Change	Previous/Current Rating
February 26, 2024	21.33%	UBS	$70 → $83	Maintain	Buy
January 23, 2024	16.94%	Cantor Fitzgerald	→ $80	Coverage Initiated	→ Overweight
01/19/2024	14.02%	Raymond James	$62 → $78	Maintain	Outperform
01/16/2024	9.63%	Barclays	$70 → $75	Maintain	Overweight
01/12/2024	9.63%	Citigroup	$61 → $75	Maintain	Buy
May 12, 2023	2.32%	Barclays	$75 → $70	Maintain	Overweight
12/01/2023	2.32%	UBS	$75 → $70	Maintain	Buy
12/01/2023	2.32%	Piper Sandler	$75 → $70	Maintain	Overweight
12/01/2023	9.63%	Benchmark	→ $75	Reiterate	Buy → Buy
12/01/2023	-4.98%	Susquehanna	$70 → $65	Maintain	Positive
12/01/2023	-7.91%	Morgan Stanley	$65 → $63	Maintain	Equal-weight
12/01/2023	-9.37%	Raymond James	$64 → $62	Maintain	Outperform
12/01/2023	-4.98%	Needham	→ $65	Reiterate	Buy → Buy
12/01/2023	46.18%	Rosenblatt	→ $100	Reiterate	Buy → Buy
12/01/2023	2.32%	Keybanc	$80 → $70	Maintain	Overweight
11/30/2023	46.18%	Rosenblatt	→ $100	Reiterate	Buy → Buy

11/14/2023: Roth MKM initiated coverage with a target price of $60, a decrease of 12.29%, recommending a buy.
08/25/2023: B of A Securities maintained a target price at $75, down from $80, with a 9.63% change, advising to buy.
08/25/2023: Morgan Stanley kept the target price at $65, down from $68, with a 4.98% change, rating it as equal weight.
08/25/2023: B. Riley Securities maintained a target price at $77, up from $75, with a 12.56% change, suggesting a buy.
08/25/2023: Oppenheimer reiterated a target price of $70, up by 2.32%, outperforming the market.
08/25/2023: Needham reiterated a target price of $65, with a 4.98% change, recommending to buy.
08/25/2023: Rosenblatt reiterated a target price of $100, up by 46.18%, advising to buy.
08/23/2023: Susquehanna maintained a target price at $70, up from $60, with a 2.32% change, showing a positive outlook.
08/22/2023: Rosenblatt reiterated a target price of $100, up by 46.18%, suggesting a buy.
08/18/2023: B. Riley Securities upgraded the target price from $60 to $75, with a 9.63% change, changing the rating from neutral to buy.
07/20/2023: Stifel maintained a target price at $75, up from $65, with a 9.63% change, recommending to buy.
07/20/2023: Barclays maintained a target price at $75, up from $55, with a 9.63% change, rating it as overweight.
07/20/2023: Wolfe Research initiated coverage with a target price of $80, up by 16.94%, outperforming the market.
07/11/2023: Keybanc maintained a target price at $80, up from $70, with a 16.94% change, rating it as overweight.
06/21/2023: Stifel reiterated a target price of $65, with a 4.98% change, recommending to buy.
06/16/2023: Morgan Stanley maintained a target price at $68, up from $55, with a 0.6% change, rating it as equal weight.
05/30/2023: Goldman Sachs maintained a target price at $60, up from $46, with a 12.29% change, advising to buy.
05/26/2023: J.P. Morgan maintained a target price at $70, up from $60, with a 2.32% change, rating it as overweight. | 05/26/2023 | -2.06% | Craig-Hallum | $56 → $67 | Maintain | Buy | | 05/26/2023 | 2.32% | Oppenheimer | → $70 | Reiterate | Outperform → Outperform | | 05/26/2023 | 2.32% | Evercore ISI Group | $60 → $70 | Maintain | Outperform | | 05/26/2023 | -6.45% | Raymond James | $50 → $64 | Maintain | Outperform | | 05/26/2023 | -19.6% | Morgan Stanley | $45 → $55 | Maintain | Equal weight | | 05/26/2023 | -12.29% | Susquehanna | $53 → $60 | Maintain | Positive | | 05/26/2023 | -4.98% | Wells Fargo | $54 → $65 | Maintain | Overweight | | 05/26/2023 | -4.98% | TD Cowen | $50 → $65 | Maintain | Outperform | | 05/26/2023 | -4.98% | Stifel | $56 → $65 | Maintain | Buy | | 05/26/2023 | 2.32% | B of A Securities | $51 → $70 | Maintain | Buy | | 05/26/2023 | 46.18% | Rosenblatt | → $100 | Reiterate | Buy → Buy | | 05/26/2023 | -4.98% | Needham | $50 → $65 | Reiterate | Buy → Buy | | 05/26/2023 | -19.6% | Barclays | $45 → $55 | Maintain | Overweight | | 05/26/2023 | -10.83% | Citi Group | $58 → $61 | Maintain | Buy | | 05/26/2023 | -4.98% | Deutsche Bank | $50 → $65 | Maintain | Buy | | 05/26/2023 | 2.32% | Keybanc | $60 → $70 | Maintain | Overweight | | 05/19/2023 | 2.32% | Oppenheimer | → $70 | Reiterate | Outperform → Outperform |
04/19/2023: Stifel downgraded from $58 to $56, maintaining a buy rating with a decrease of 18.14%.
03/23/2023: B of A Securities reiterated a neutral rating at $51, with a decrease of 25.45%.
03/09/2023: Susquehanna reiterated a positive rating at $50, with a decrease of 26.91%.
03/06/2023: Goldman Sachs downgraded from $54 to $46, maintaining a buy rating with a decrease of 32.76%.
03/03/2023:
- Craig-Hallum downgraded from $63 to $56, maintaining a buy rating with a decrease of 18.14%.
- Morgan Stanley maintained an equal weight rating at $45, with a decrease of 34.22%.
- TD Cowen maintained an outperform rating at $50, with a decrease of 26.91%.
- B of A Securities maintained a buy rating at $51, with a decrease of 25.45%.
- Citigroup maintained a buy rating at $58, with a decrease of 15.22%.
- Piper Sandler maintained an overweight rating at $50, with a decrease of 26.91%.
- JPMorgan Chase maintained an overweight rating at $60, with a decrease of 12.29%.
- Credit Suisse maintained an outperform rating at $53, with a decrease of 22.53%.
- Deutsche Bank maintained a buy rating at $50, with a decrease of 26.91%.
- Susquehanna maintained a positive rating at $50, with a decrease of 26.91%.
- Raymond James maintained an outperform rating at $50, with a decrease of 26.91%.
- Needham maintained a buy rating at $50, with a decrease of 26.91%.
03/03/2023: Rosenblatt maintains a buy rating on $125 to $100. Keybanc maintains an overweight rating on $65 to $60.
03/02/2023: Raymond James downgrades to outperform from beating the market at $54.
03/01/2023: Rosenblatt reiterates a buy rating at $125.
02/22/2023: Susquehanna maintains a positive rating on $60 to $55.
01/23/2023: Barclays maintains an overweight rating on $55 to $45.
12/15/2022: Evercore ISI Group maintains an outperform rating on $70 to $60.
12/02/2022: Craig-Hallum maintains a buy rating on $90 to $63. TD Cowen maintains an outperform rating on $70 to $55. Citi Group maintains a buy rating on $71 to $65. Morgan Stanley maintains an equal weight rating on $60 to $41. UBS maintains a buy rating on $80 to $75. JPMorgan maintains an overweight rating on $75 to $72. Goldman Sachs maintains a buy rating on $62 to $54. Wells Fargo maintains an overweight rating on $58 to $54. Barclays maintains an overweight rating on $60 to $55. Raymond James maintains an outperform rating on $80 to $60.
12/02/2022: Piper Sandler downgraded from $80 to $55, rating maintained at overweight, a decrease of 19.6%. Needham downgraded from $64 to $50, rating maintained at buy, a decrease of 26.91%. Keybanc downgraded from $75 to $65, rating maintained at overweight, a decrease of 4.98%.
11/28/2022: Oppenheimer upgraded from $90 to $80, rating maintained at outperform, an increase of 16.94%.
11/16/2022: Credit Suisse initiated coverage at $56, outperforming the market, with a decrease of 18.14%.
10/18/2022: Deutsche Bank downgraded from $65 to $55, rating maintained at buy, a decrease of 19.6%.
10/11/2022: Citigroup downgraded from $74 to $71, rating maintained at buy, a decrease of 3.79%. Wells Fargo downgraded to $58, upgraded to overweight from equal weight, a decrease of 15.22%.
04/10/2022: B. Riley Securities downgraded from $63 to $52, rating maintained at neutral, a decrease of 23.99%.
09/29/2022: Stifel downgraded from $78 to $70, rating maintained at buy, a decrease of 2.32%.
09/13/2022: Exane BNP Paribas initiated coverage at $62, outperforming the market, with a decrease of 9.37%.
08/29/2022: Citigroup downgraded from $78 to $74, rating maintained at buy, a decrease of 8.17%.
08/26/2022: Morgan Stanley downgraded from $62 to $60, rating maintained at equal weight, a decrease of 12.29%. Goldman Sachs downgraded from $55 to $62, rating maintained at buy, a decrease of 9.37%. Wells Fargo downgraded from $65 to $58, rating maintained at equal weight, a decrease of 15.22%. Keybanc downgraded from $90 to $75, rating maintained at overweight, an increase of 9.63%.
07/25/2022: Barclays downgraded from $80 to $60, rating maintained at overweight, a decrease of 12.29%.
07/22/2022: Benchmark at 2.32%, target price of $70 → Buy
07/20/2022: Deutsche Bank at -4.98%, price from $75 to $65, maintain Buy
07/18/2022: Evercore ISI Group at 2.32%, price from $85 to $70, outperform market
06/29/2022: B of A Securities at -12.29%, price from $90 to $60, maintain Buy
06/15/2022: B. Riley Securities at -7.91%, price from $75 to $63, downgrade from Buy to Neutral
06/10/2022: Morgan Stanley at -9.37%, price from $68 to $62, maintain Equal Weight
05/27/2022: Citigroup at 14.02%, price from $90 to $78, maintain Buy
05/27/2022: BMO Capital at 19.87%, price from $98 to $82, outperform market
05/27/2022: Cowen & Co. at 24.25%, price from $100 to $85, outperform market
05/27/2022: B of A Securities at 31.56%, price from $100 to $90, maintain Buy
05/27/2022: Morgan Stanley at -0.6%, price from $80 to $68, maintain Equal Weight
05/27/2022: Needham at 9.63%, price from $105 to $75, maintain Buy
05/27/2022: Keybanc at 31.56%, price from $95 to $90, maintain Overweight
05/25/2022: Susquehanna at 31.56%, price from $105 to $90, maintain Positive
05/23/2022: B. Riley Securities at 5.25%, price from $95 to $72, maintain Buy
05/23/2022: UBS at 16.94%, price from $95 to $80, maintain Buy
05/20/2022: Oppenheimer at 31.56%, price from $110 to $90, outperform market
04/25/2022: Barclays maintains overweight rating on $90 to $80, downgraded by Raymond James to market perform from outperform.
04/20/2022: Deutsche Bank maintains buy rating on $90 to $80.
03/07/2022: Susquehanna maintains positive outlook on $100 to $105.
03/04/2022: Summit Insights downgrades buy to hold, Morgan Stanley maintains equal weight on $86 to $80, B. Riley Securities maintains buy on $115 to $95, Deutsche Bank maintains buy on $100 to $90, Wells Fargo maintains equal weight on $80 to $70, Rosenblatt maintains buy on $120 to $125, Needham maintains buy on $115 to $105.
04/01/2022: Needham maintains buy on $100 to $115.
12/21/2021: Citigroup maintains buy on $87 to $97.

03/12/2021: B of A Securities maintains buy on $80 to $115, Citigroup maintains buy on $70 to $87, Deutsche Bank maintains buy on $76 to $100, Oppenheimer maintains outperform on $100 to $110.

Date	Percentage	Analyst	Previous Price	Recommendation	Action
March 12, 2021	75.41%	Rosenblatt	$100 → $120	Maintain	Buy
March 12, 2021	46.18%	Cowen & Co.	$66 → $100	Upgrade	Outperform → Beat the market
March 12, 2021	46.18%	Needham	$75 → $100	Maintain	Buy
March 12, 2021	25.71%	Morgan Stanley	$63 → $86	Maintain	Equal weight
March 12, 2021	46.18%	Stifel	$80 → $100	Maintain	Buy
March 12, 2021	68.1%	B. Riley Securities	$90 → $115	Maintain	Buy
March 12, 2021	38.87%	Goldman Sachs	$63 → $95	Upgrade	Neutral → Buy
March 12, 2021	16.94%	Wells Fargo	$62 → $80	Maintain	Equal weight
March 12, 2021	43.25%	BMO Capital	$85 → $98	Maintain	Beat the market
March 12, 2021	53.49%	Credit Suisse	$85 → $105	Maintain	Beat the market
March 12, 2021	38.87%	UBS	$87 → $95	Maintain	Buy
March 12, 2021	38.87%	Keybanc	$80 → $95	Maintain	Overweight
December 1, 2021	19.87%	Susquehanna	$75 → $82	Maintain	Positive
November 29, 2021	31.56%	B. Riley Securities	$83 → $90	Maintain	Buy
November 23, 2021	46.18%	Oppenheimer	$75 → $100	Maintain	Beat the market
July 10, 2021	-3.52%	TD Cowen	$57 → $66	Maintain	Market perform

July 10, 2021
- 16.94% increase
  - B of A Securities
  - Price target: $75 → $80
  - Rating: Maintain Buy
- -7.91% decrease
  - Morgan Stanley
  - Price target: $61 → $63
  - Rating: Maintain Equal Weight
- 21.33% increase
  - B. Riley Securities
  - Price target: $75 → $83
  - Rating: Maintain Buy
- 19.87% increase
  - Jefferies Group
  - Price target: $78 → $82
  - Rating: Maintain Buy
- 24.25% increase
  - Craig-Hallum
  - Price target: $63 → $85
  - Rating: Upgrade from Hold to Buy
- 9.63% increase
  - Needham
  - Price target: $69 → $75
  - Rating: Maintain Buy
- 46.18% increase
  - Rosenblatt
  - Price target: $85 → $100
  - Rating: Maintain Buy
- 24.25% increase
  - Credit Suisse
  - Price target: $70 → $85
  - Rating: Maintain Outperform
- 16.94% increase
  - Keybanc
  - Price target: $70 → $80
  - Rating: Maintain Overweight
September 28, 2021
- -16.68% decrease
  - TD Cowen
  - Price target: N/A → $57
  - Rating: Reiterate Market Perform

August 27, 2021

-16.68% decrease
- TD Cowen
- Price target: $55 → $57
- Rating: Maintain Market Perform
9.63% increase
- B of A Securities
- Price target: $74 → $75
- Rating: Maintain Buy
2.32% increase
- Citi Group
- Price target: $64 → $70
- Rating: Maintain Buy
-7.91% decrease
- Craig-Hallum
- Price target: N/A → $63
- Rating: Downgrade from Buy to Hold
-10.83% decrease
- Morgan Stanley
- Price target: $57 → $61
- Rating: Maintain Equal Weight

-9.37% decrease

Wells Fargo
Price target: $50 → $62

Rating: Maintain Equal Weight

Date	Change	Company	Price Target	Recommendation	Rating
08/27/2021	0.86%	Nidum	$67.5 → $69	Maintain	Buy
08/27/2021	9.63%	Aobenheimer	$70 → $75	Maintain	Outperform
08/27/2021	2.32%	Barclays	$60 → $70	Maintain	Overweight
08/27/2021	2.32%	Keybanc	$65 → $70	Maintain	Overweight
08/23/2021	-19.6%	TD Cowen	$50 → $55	Maintain	Market Perform
08/23/2021	-16.68%	Morgan Stanley	$49 → $57	Maintain	Equal-weight
08/04/2021	2.32%	Credit Suisse	$60 → $70	Maintain	Outperform
08/04/2021	-1.33%	Nidum	$55 → $67.5	Maintain	Buy
07/15/2021	8.17%	B of A Securities	$62 → $74	Maintain	Buy
06/07/2021	-4.98%	Keybanc	$60 → $65	Maintain	Overweight
06/08/2021	-9.37%	B of A Securities	$60 → $62	Maintain	Buy
06/08/2021	-12.29%	Keybanc	$55 → $60	Maintain	Overweight
06/08/2021	-19.6%	Nidum	$50 → $55	Maintain	Buy
06/08/2021	2.32%	Rosenblatt	$60 → $70	Maintain	Buy
05/13/2021	-26.91%	Nidum	$47 → $50	Maintain	Buy
04/26/2021	-12.29%	B of A Securities	$58 → $60	Maintain	Buy
08/03/2021	-26.91%	BMO Capital	$45 → $50	Upgrade	Market Perform → Outperform

03/01/2021: Morgan Stanley downgraded from $44 to $49, maintaining an 'Equal Weight' rating.
01/25/2021: Citigroup Group increased from $50 to $64, maintaining a 'Buy' rating.
December 14, 2020: Morgan Stanley downgraded from $42 to $44, maintaining an 'Equal Weight' rating.
12/04/2020: Morgan Stanley downgraded from $40 to $42, maintaining an 'Equal Weight' rating.
10/30/2020: Craig-Hallum upgraded from $44 to $48, changing from 'Hold' to 'Buy'.
10/30/2020: Morgan Stanley downgraded from $37 to $40, maintaining an 'Equal Weight' rating.
10/20/2020: Keybanc resumed coverage at $55, changing to 'Overweight'.
September 10, 2020: Citigroup Group increased from $43 to $50, maintaining a 'Buy' rating.
September 10, 2020: Craig-Hallum downgraded from 'Buy' to 'Hold'.
September 10, 2020: Benchmark increased from $40 to $50, maintaining a 'Buy' rating.
September 10, 2020: Needham increased from $39 to $47, maintaining a 'Buy' rating.
June 10, 2020: UBS maintained a 'Buy' rating, increasing from $38 to $47.
May 10, 2020: B. Riley Securities reiterated a 'Buy' rating, increasing from $42 to $48.
10/02/2020: Rosenblatt reiterated a 'Buy' rating, increasing from $50 to $60.
February 9, 2020: Argus Research maintained a 'Buy' rating, increasing from $40 to $50.
08/28/2020: Rosenblatt maintained a 'Buy' rating, increasing from $42 to $50.

08/28/2020: Morgan Stanley maintained an 'Equal Weight' rating, increasing from $36 to $37.

Date	Change	Analyst Firm	Price Target	Action	Previous Rating -> New Rating
08/28/2020	-54.68%	Cowen & Co.	→ $31	Upgrade	Underperform -> Market Perform
08/27/2020	-34.22%	Credit Suisse	→ $45	Reiterate	-> Outperforming the Market
08/03/2020	-26.91%	B of A Securities	$45 → $50	Maintain	Buy
07/20/2020	-41.53%	Barclays	$35 → $40	Maintain	Overweight
07/15/2020	-48.84%	Wells Fargo	→ $35	Downgrade	Overweight -> Equal Weight
06/29/2020	-44.45%	UBS	$35 → $38	Maintain	Buy
06/16/2020	-47.38%	Morgan Stanley	$33.5 → $36	Maintain	Equal-weight
06/01/2020	-51.03%	Morgan Stanley	$25 → $33.5	Maintain	Equal-weight
05/29/2020	-48.84%	CFRA	$27 → $35	Maintain	Buy
05/29/2020	-44.45%	B. Riley Securities	$34 → $38	Maintain	Buy
05/29/2020	-51.03%	Morgan Stanley	$25 → $33.5	Maintain	Equal-weight
05/29/2020	-38.61%	Rosenblatt	$32 → $42	Reiterate	-> Buy
05/29/2020	-50.3%	Needham	$28 → $34	Maintain	Buy
05/27/2020	-48.84%	Benchmark	$30 → $35	Maintain	Buy
05/22/2020	-50.3%	B. Riley Securities	$31 → $34	Maintain	Buy
05/21/2020	-48.84%	Citigroup	$31 → $35	Maintain	Buy
04/15/2020	-59.07%	Needham	$29 → $28	Maintain	Buy
Date	Change	Analyst	Price Target	Recommendation	Action
---	---	---	---	---	---
April 13, 2020	-54.68%	B. Riley Securities	$25 → $31	Maintain	Buy
March 19, 2020	-63.46%	B. Riley Securities	$32 → $25	Maintain	Buy
03/06/2020	-54.68%	Citigroup	$30 → $31	Maintain	Buy
03/05/2020	-53.22%	Stifel	$30 → $32	Maintain	Buy
03/05/2020	-53.22%	Piper Sandler	$30 → $32	Reiterate	Overweight
03/05/2020	-63.46%	Morgan Stanley	$24 → $25	Maintain	Equal-weight
03/05/2020	-53.22%	B. Riley Securities	$28 → $32	Maintain	Buy
03/02/2020	-59.07%	B. Riley Securities	$32 → $28	Maintain	Buy
02/11/2020	-56.15%	Sumitomo Mitsui Banking Corporation	→ $30	Coverage Initiated	Outperform Market
02/07/2020	-73.69%	Cowen & Co.	$27 → $18	Downgrade	Outperform Market → Underperform
12/05/2019	-56.15%	Citigroup	$29 → $30	Maintain	Buy
April 12, 2019	-54.68%	JPMorgan	$27 → $31	Maintain	Overweight
April 12, 2019	-64.92%	Morgan Stanley	$20 → $24	Maintain	Equal-weight
April 12, 2019	—	BMO Capital		Downgrade	Outperform Market → Market Perform
11/04/2019	-53.22%	Wells Fargo	$25 → $32	Upgrade	Market Perform → Outperform Market
10/04/2019	-57.61%	Stifel	→ $29	Resumed Coverage	→ Buy
08/30/2019	—	Craig-Hallum		Upgrade	Hold → Buy
08/21/2019	-56.15%	Benchmark	→ $30	Assume	→ Buy
07/22/2019	-63.46%	Goldman Sachs	$24 → $25	Downgrade	Buy → Neutral
07/17/2019	-56.15%	Citigroup	$27 → $30	Maintain	Buy
07/15/2019	—	William Blair		Coverage Initiated	→ Outperform Market
06/19/2019	—	Raymond James		Coverage Initiated	→ Market Perform
05/31/2019	-59.07%	B. Riley Securities	$30 → $28	Maintain	Buy
05/31/2019	-70.76%	Morgan Stanley	$19 → $20	Maintain	Equal-weight
05/31/2019	-60.53%	Citigroup	$28 → $27	Maintain	Buy
05/31/2019	-59.07%	MKM Partners	$25 → $28	Maintain	Buy
05/15/2019	-64.92%	Wells Fargo	→ $24	Coverage Initiated	→ Market Perform
April 24, 2019	-57.61%	UBS	$22 → $29	Maintain	Buy
04/17/2019	-59.07%	B of A Securities	$24 → $28	Reiterate	→ Buy
04/17/2019	-59.07%	Citigroup	$22 → $28	Maintain